Skip to content

NEURALGO

Active Private limited companyfounded 2014active for 12 yearsBossuytlaan 28, 8310 BrugesKBO/BCE: BE 0555.873.742

Lifetime

11 annual accounts with figures on one time axis
peak of €545,694 in 2025
€545,694▲ 36.0%
peak of €262,977 in 2025
€262,977▲ 68.6%
peak of €723,098 in 2024
€630,751▼ 12.8%
€1.2m▲ 23.3%
Board4 names since 2014
4 directors and 3 others
Documentsfilings and deeds
29-06-20261 day before the deadline
2025micro format
Gross margin from €401,156 to €545,694Result from €155,982 to €262,977Dividend €355,324Equity from €723,098 to €630,751Debts from €950,309 to €1.2mCash from €111,772 to €271,031

Key points

from the 2025 annual accounts

Equity

€630,751 ▼ 12.8%
723,0982024+262,977Profit-355,324Dividend630,7512025

NEURALGO paid out €355,324 in dividends. That is 135% of the 2025 profit.

Result

€262,977 ▲ 68.6%
€156,0002024€263,0002025

The result rose in 2025 from €155,982 to €262,977.

Turnover

≈ €820,000 estimated

The micro format states no turnover.

Investments

€27,426 0.2 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Filings

11 annual accounts since 2015
deadline201520202025

The last five annual accounts were filed 0 to 4 days before the end of the period.

Position in the sector

€262,977

Higher net result than 93% of companies in human health. The sector median is €59,520, over 21,355 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as NEURALGO has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for NEURALGO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 19-06-2014
Manager, since 19-06-2014
Director, since 19-06-2014
Manager, since 19-06-2014
  • 93 sharesdeed of 18-07-2014
  • 93 sharesdeed of 18-07-2014
Board & ownership

Recent changes

Environmental permit granted Outbuildings · decided by Bruges
Company renamed from Dr.HANSSENS-Dr.VERMEERSCH to NEURALGO (manager) and (manager) resign · (director) and (director) reappointed · General meeting of 29-11-2023 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0555873742
Environmental permit granted Outbuildings, Outbuildings, Convert or extend · decided by Bruges
All 26 events

Comparable companies

same main activity, similar in size and age
Company
NEURALGO Bruges €1.8m €545,694 35.0% -
MontiNefro Bruges €2.0m €530,936 83.3% -
DR. LIESBETH LAUREYN Tessenderlo-Ham €1.8m €540,405 52.0% -
OOGCHIRURGIE DR. VAN SLYCKEN -DR.CANDAELE Ghent €1.9m €559,026 31.2% 2.3
Medisch Centrum Wijnegem Wijnegem €1.7m €587,502 0.8% -
DR.A.DE SCHEPPER MEDISCHE BEELDVORMING Ranst €1.6m €509,411 73.6% -
Dr. Jeroen Herbots Landen €2.0m €532,844 47.1% -

These companies have the same main activity as NEURALGO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.6m and €2m, founded between 2012 and 2015.

Official details

Source: KBO
Status
Active since 19-06-2014Normal situation
Activity
Specialist medical practiceNACE 86220and 2 others
Establishment unit
2.233.617.0208310 Bruges, registered on 20-06-2014
Financial year end
30 November
Peppol
Reachable since 24-11-2023
Company details

Annual accounts to 30-11-2025

€1.8m▲ 7.7%
Filing
Filed on 29-06-2026, 1 day before the end of the filing period
Financials

Insights on NEURALGO

NEURALGO files the micro format. That format states no turnover. The gross margin rose from €257,320 in 2015 to €545,694 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NEURALGO

What is the company number of NEURALGO?
The company number of NEURALGO is 0555.873.742. The VAT number is the same number with BE in front: BE 0555.873.742.
Where is NEURALGO based?
The registered office is at Bossuytlaan 28, 8310 Bruges.Company details
What does NEURALGO do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of NEURALGO?
NEURALGO is a private limited company (BV).
When was NEURALGO founded?
NEURALGO was founded on 19-06-2014.
Is NEURALGO still active?
Yes, NEURALGO is an active enterprise in the KBO register.
What is the turnover of NEURALGO?
The turnover in financial year 2025 is about €820,000. This figure is estimated from the gross margin of €545,694 and 31 comparable companies (NACE 86220). It probably lies between €730,000 and €1.1m.Financials
Is NEURALGO profitable?
In financial year 2025, NEURALGO made a profit of €262,977.
Where can I find the annual accounts of NEURALGO?
NEURALGO filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NEURALGO due?
NEURALGO must file the annual accounts for financial year 2026 by 30-06-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.